Birchview Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-82,000
| Closed | -$113K | – | 69 |
|
|
2024
Q4 | $113K | Sell |
82,000
-290,000
| -78% | -$400K | 0.09% | 62 |
|
|
2024
Q3 | $387K | Buy |
372,000
+102,000
| +38% | +$106K | 0.34% | 36 |
|
|
2024
Q2 | $467K | Hold |
270,000
| – | – | 0.43% | 33 |
|
|
2024
Q1 | $645K | Buy |
270,000
+160,000
| +145% | +$382K | 0.53% | 31 |
|
|
2023
Q4 | $366K | Buy |
+110,000
| New | +$366K | 0.29% | 40 |
|
|
2017
Q1 | – | Sell |
-7,500
| Closed | -$211K | – | 43 |
|
|
2016
Q4 | $211K | Hold |
7,500
| – | – | 0.13% | 35 |
|
|
2016
Q3 | $201K | Hold |
7,500
| – | – | 0.12% | 37 |
|
|
2016
Q2 | $127K | Hold |
7,500
| – | – | 0.09% | 43 |
|
|
2016
Q1 | $159K | Hold |
7,500
| – | – | 0.11% | 39 |
|
|
2015
Q4 | $172K | Hold |
7,500
| – | – | 0.1% | 40 |
|
|
2015
Q3 | $150K | Hold |
7,500
| – | – | 0.1% | 40 |
|
|
2015
Q2 | $217K | Hold |
7,500
| – | – | 0.11% | 38 |
|
|
2015
Q1 | $229K | Buy |
+7,500
| New | +$229K | 0.12% | 37 |
|